Cited by 349Hormonal and reproductive studiesGrowth Hormone and Insulin-like Growth FactorsMenopause: Health Impacts and Treatments

The physiology of endocrine systems with ageing

Open access
van den Beld, Annewieke W, Kaufman, Jean-Marc, Zillikens, M Carola, Lamberts, Steven W J, Egan, Josephine M, van der Lely, Aart J·2018·The Lancet Diabetes & Endocrinology

Abstract

During ageing, the secretory patterns of the hormones produced by the hypothalamic–pituitary axis change, as does the sensitivity of the axis to negative feedback by end hormones. Additionally, glucose homoeostasis tends towards disequilibrium with increasing age. Along with these endocrine alterations, a loss of bone and muscle mass and strength occurs, coupled with an increase in fat mass. In addition, ageing-induced effects are difficult to disentangle from the influence of other factors that are common in older people, such as chronic diseases, inflammation, and low nutritional status, all of which can also affect endocrine systems. Traditionally, the decrease in hormone activity during the ageing process has been considered to be detrimental because of the related decline in bodily functions. The concept of hormone replacement therapy was suggested as a therapeutic intervention to stop or reverse this decline. However, clearly some of these changes are a beneficial adaptation to ageing, whereas hormonal intervention often causes important adverse effects. In this paper, we discuss the effects of age on the different hypothalamic–pituitary–hormonal organ axes, as well as age-related changes in calcium and bone metabolism and glucose homoeostasis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(18)30026-3

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FPG does not increase significantly after age 60, but 2-h glucose concentrations during a 75-g OGTT are considerably higher in older people.

    “FPG does not increase significantly after age 60, but 2-h glucose concentrations during a 75-g OGTT are considerably higher in older people (98,99).”

    From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [98]

    The Glucose homoeostasis section reports that glucose concentrations two hours after a 75-g oral glucose tolerance test gradually increase with age. It does not describe that increase as considerable; it also reports that fasting plasma glucose rises by approximately 0.055 mmol/L per decade, without stating that the rise becomes statistically insignificant after age 60. No page number is available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • FPG increases with increasing age beginning in the third to fourth decade.

    “FPG increases with increasing age beginning in the third to fourth decade (97,98).”
  • Glucose homeostasis is impaired with aging.

    “Glucose homeostasis is impaired with aging.”
  • During ageing, hormones including gonadal hormones, glucocorticoids, thyroid hormones and insulin are perturbed due to dysregulation of the hypothalamic-pituitary-gonadal, hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axes, leading to age-related diseases.

    “During the ageing process, these hormones are perturbed due to dysregulation of the major endocrine axes, including the hypothalamic–pituitary–gonadal (HPG) axis, hypothalamic–pituitary–adrenal (HPA) axis and hypothalamic–pituitary–thyroid (HPT) axis, leading to age-related diseases.349”
  • Regulating hormone levels appropriately to adapt to age-related changes is advantageous in delaying age-related diseases.

    “regulating hormone levels appropriately to adapt to age-related changes is advantageous in delaying age-related diseases.349”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
van den Beld, A. W., Kaufman, J.-M., Zillikens, M. C., Lamberts, S. W. J., Egan, J. M., & van der Lely, A. J.
Affiliations
  • Ghent University Hospital (BE)
  • Erasmus MC (NL)
  • National Institute on Aging (US)
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2018-08
Volume
6
Issue
8
Pages
647-658
ISSN
2213-8587 (ISSN-L)
OpenAlex
W2883912013
Cited by
349
References
123
Citations by year
2026: 37 · 2025: 45 · 2024: 63 · 2023: 68 · 2022: 43 · 2021: 55 · 2020: 21 · 2019: 14 · 2018: 2 · 2016: 1
FWCI
3.54
Type
journal article
Language
en
Open access
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Funders
National Institutes of Health (Z99 AG999999)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
aging, endocrine system, hypothalamic-pituitary axis, negative feedback, glucose homeostasis, bone loss, muscle mass and strength, fat mass, chronic disease, inflammation, nutritional status, hormone replacement therapy, adverse effects
MeSH terms
Aging, Endocrine System, Hormones, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review